FDA
-
-
-
-
-
-
-
Madrigal Pharmaceuticals adds J&J executive to its board
-
-
-
-
-
-
-
Madrigal Pharmaceuticals receives three new resmetirom patents
-
-
-
-
-
-
-
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
Madrigal Pharmaceuticals to Release First-Quarter 2026 Financial Results and Host Webcast on May 6, 2026
-
-
-
-
-
-
-
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
Madrigal Pharmaceuticals Announces Grant of Inducement Award under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
-
334,646 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


